BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 32503342)

  • 1. A Novel, Pan-PDE Inhibitor Exerts Anti-Fibrotic Effects in Human Lung Fibroblasts via Inhibition of TGF-β Signaling and Activation of cAMP/PKA Signaling.
    Wójcik-Pszczoła K; Chłoń-Rzepa G; Jankowska A; Ślusarczyk M; Ferdek PE; Kusiak AA; Świerczek A; Pociecha K; Koczurkiewicz-Adamczyk P; Wyska E; Pękala E; Gosens R
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
    Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts.
    Togo S; Liu X; Wang X; Sugiura H; Kamio K; Kawasaki S; Kobayashi T; Ertl RF; Ahn Y; Holz O; Magnussen H; Fredriksson K; Skold CM; Rennard SI
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L959-69. PubMed ID: 19304913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AITC inhibits fibroblast-myofibroblast transition via TRPA1-independent MAPK and NRF2/HO-1 pathways and reverses corticosteroids insensitivity in human lung fibroblasts.
    Yap JMG; Ueda T; Kanemitsu Y; Takeda N; Fukumitsu K; Fukuda S; Uemura T; Tajiri T; Ohkubo H; Maeno K; Ito Y; Oguri T; Ugawa S; Niimi A
    Respir Res; 2021 Feb; 22(1):51. PubMed ID: 33579280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel phosphodiesterases inhibitors from the group of purine-2,6-dione derivatives as potent modulators of airway smooth muscle cell remodelling.
    Wójcik-Pszczoła K; Chłoń-Rzepa G; Jankowska A; Ellen E; Świerczek A; Pociecha K; Koczurkiewicz P; Piska K; Gawędzka A; Wyska E; Knapik-Czajka M; Pękala E; Gosens R
    Eur J Pharmacol; 2019 Dec; 865():172779. PubMed ID: 31705904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiestrase-1 and 4 inhibitors ameliorate liver fibrosis in rats: Modulation of cAMP/CREB/TLR4 inflammatory and fibrogenic pathways.
    Essam RM; Ahmed LA; Abdelsalam RM; El-Khatib AS
    Life Sci; 2019 Apr; 222():245-254. PubMed ID: 30858122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia.
    Zhang L; Murray F; Zahno A; Kanter JR; Chou D; Suda R; Fenlon M; Rassenti L; Cottam H; Kipps TJ; Insel PA
    Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19532-7. PubMed ID: 19033455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K+ channels and the cAMP-PKA pathway modulate TGF-beta1-induced migration of rat vascular myofibroblasts.
    Liu YR; Ye WL; Zeng XM; Ren WH; Zhang YQ; Mei YA
    J Cell Physiol; 2008 Sep; 216(3):835-43. PubMed ID: 18551429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3 (GSK-3) regulates TGF-β₁-induced differentiation of pulmonary fibroblasts.
    Baarsma HA; Engelbertink LH; van Hees LJ; Menzen MH; Meurs H; Timens W; Postma DS; Kerstjens HA; Gosens R
    Br J Pharmacol; 2013 Jun; 169(3):590-603. PubMed ID: 23297769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors.
    Martin-Chouly CA; Astier A; Jacob C; Pruniaux MP; Bertrand C; Lagente V
    Life Sci; 2004 Jul; 75(7):823-40. PubMed ID: 15183075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of phosphodiesterase PDE-3/PDE-4-specific inhibitors on vasoconstriction and cAMP-dependent vasorelaxation following balloon angioplasty.
    Zhao H; Quilley J; Montrose DC; Rajagopalan S; Guan Q; Smith CJ
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2973-81. PubMed ID: 17293498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases.
    Guo L; Luo L; Ju R; Chen C; Zhu L; Li J; Yu X; Ye C; Zhang D
    Eur J Pharmacol; 2015 Jan; 746():14-21. PubMed ID: 25446933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
    Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
    Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of a phosphodiesterase III in the lysis-sensitive target-induced elevation of cyclic AMP (cAMP) in human natural killer cells.
    Whalen MM; Crews JD
    Biochem Pharmacol; 2000 Aug; 60(4):499-506. PubMed ID: 10874124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Inhibitory Function of TRPA1 Channels in TGF-β1-driven Fibroblast-to-Myofibroblast Differentiation.
    Geiger F; Zeitlmayr S; Staab-Weijnitz CA; Rajan S; Breit A; Gudermann T; Dietrich A
    Am J Respir Cell Mol Biol; 2023 Mar; 68(3):314-325. PubMed ID: 36378826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons.
    Sasaki T; Kotera J; Omori K
    J Neurochem; 2004 Apr; 89(2):474-83. PubMed ID: 15056290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors.
    Liu S; Veilleux A; Zhang L; Young A; Kwok E; Laliberté F; Chung C; Tota MR; Dubé D; Friesen RW; Huang Z
    J Pharmacol Exp Ther; 2005 Aug; 314(2):846-54. PubMed ID: 15901792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-dependent balance of mitogenic effects in primary human lung fibroblasts related to cyclic AMP signaling and phosphodiesterase 4 inhibition.
    Selige J; Tenor H; Hatzelmann A; Dunkern T
    J Cell Physiol; 2010 May; 223(2):317-26. PubMed ID: 20082309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular mechanisms underlying prostaglandin-induced transient cAMP signals near the plasma membrane of HEK-293 cells.
    Rich TC; Xin W; Mehats C; Hassell KA; Piggott LA; Le X; Karpen JW; Conti M
    Am J Physiol Cell Physiol; 2007 Jan; 292(1):C319-31. PubMed ID: 16899551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.